Press Releases Sanofi OTC Markets

Equities

SNYNF

FR0000120578

Market Closed - OTC Markets Other stock markets 01:02:55 2024-06-26 pm EDT			5-day change	1st Jan Change
95.5 ^USD	-0.52%		+0.23%	-4.13%

Jun. 27	CAC40: caution prevails ahead of crucial deadlines	CF
Jun. 27	CAC40: consolidates solo, OAT/Bund spread widens to 81Pb	CF

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sanofi - Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM	Jun. 27	AQ
Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM	Jun. 26	GL
Press Release: Availability of the Q2 2024 Aide-mémoire	Jun. 25	GL
Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee	Jun. 21	GL
List of Companies That Allegedly Left Nigeria Under Tinubu's Presidency Is Not Accurate	Jun. 21	AQ
Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran	Jun. 21	GL
Press Release: Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in Africa	Jun. 20	GL
INNATE PHARMA SHARES UPDATED RESULTS FROM THE SANOFI DEVELOPED BLOOD CANCER PHASE SAR443579/IPH6101 TRIAL	Jun. 18	AQ
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Mai 2024	Jun. 12	PU
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development (CRDL,JAZZ, NVO, AZN, SNY)	Jun. 11	AQ
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development	Jun. 11	AQ
I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer	Jun. 07	AQ
Deerfield Management Welcomes Frank Nestle, MD, FMedSci, as Partner and Chief Executive Officer of Therapeutic Discovery and Development	Jun. 06	AQ
SANOFI : L’AMMC vise le prospectus relatif à l’augmentation de capital du groupe « SANOFI » réservée aux salariés du groupe	Jun. 04	PU
Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3	Jun. 03	GL
Sanofi - Dupixent recommended for EU approval by the CHMP to treat patients with COPD	Jun. 03	AQ
Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan	May. 31	GL
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD	May. 31	GL
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with type 2 inflammation	May. 31	GL
Largest vaccine production plant in Canada opens in Toronto	May. 30	AQ